Dual Implant Versus Single Implant Distal End of Femur
Pilot for Dual Implant Versus Single Implant Distal End of Femur (pDISIDE Femur)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic Minnesota
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Femur fracture distal to the femoral diaphysis.
- Operative treatment within 72 hours of presenting to the treating hospital.
- Patient was previously ambulatory.
- Fracture amendable to either single or dual implant fixation.
- Informed consent can be obtained from the patient, family member, or power of attorney.
Exclusion Criteria:
- Associated major lower extremity fracture.
- Ongoing infection.
- History of metabolic bone disease (Paget's, etc).
- Pathologic fracture.
- Open fracture.
- Severe cognitive impairment (Six Item Screener with 3 or more errors).
- Stage 5 Parkinson's disease.
- Significant femoral bone loss requiring planned staged bone grafting.
- Vascular injury.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Single Distal Femur Implant Group
Subjects will receive one of two types of implants for the distal femur fracture.
The single implant will be either a plate and screws or a rod.
The type of single implant used will be determined by the surgeon based on the characteristics of the fracture.
|
Single implant constructs will be either a retrograde intramedullary nail with interlocking screws or a single plate and screw construct.
|
|
Experimental: Dual Distal Femur Implant Group
Subjects will receive two implants for fixation of the distal femur fracture.
The dual implant will be either 2 plates with screws or a plate with screws and a rod.
The type of dual implant used will be determined by the surgeon based on the characteristics of the fracture.
|
Dual implant constructs will either be an intramedullary nail with an additional plate and screw construct or dual (two plates in any orientation) plate and screw construct.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of study-eligible subjects
Time Frame: Baseline
|
Total number of subjects to be enrolled in the study
|
Baseline
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative times
Time Frame: Duration of surgery, approximately 2-4 hours
|
Total recorded amount of time in minutes to complete the surgery
|
Duration of surgery, approximately 2-4 hours
|
|
Blood loss
Time Frame: Duration of surgery, approximately 2-4 hours
|
Total amount of surgical blood loss, reported in mL.
|
Duration of surgery, approximately 2-4 hours
|
|
Hospitalization days
Time Frame: approximately 2-3 days
|
Total number of days a subject requires hospitalization after surgery
|
approximately 2-3 days
|
|
Early post-surgical complications
Time Frame: 2 weeks post-surgery
|
Number of subjects to experience venous thromboembolism (VTE), cardiopulmonary, and/or infectious complications after surgery
|
2 weeks post-surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Brandon Yuan, MD, Mayo Clinic
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 22-004415
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.